Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of the 20 mL Biologic Lung Volume Reduction System (BLVR) in Patients With Advanced Upper Lobe Predominant Emphysema

NCT00515164 is registered in ClinicalTrials.gov with Aeris Therapeutics as lead sponsor.

NCT NCT00515164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00515164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of the 20 mL Biologic Lung Volume Reduction System (BLVR) in Patients With Advanced Upper Lobe Predominant Emphysema
Lead sponsor
Aeris Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
December 31, 2009
Enrollment
22 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, pulmonary emphysema